Paperpal Prime Logo

BMC Cardiovascular Disorders : Impact Factor & More

eISSN: 1471-2261pISSN: 1471-2261
JournalOpen Access

Key Metrics

CiteScore
2.6
Impact Factor
< 5
Scite Index
0.82 5-Year SI
SJR
Q2Cardiology and Cardiovascular Medicine
SNIP
0.88
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on BMC Cardiovascular Disorders

BMC Cardiovascular Disorders Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher BMC
Language English
Frequency Continuous publication
Article Processing ChargesEUR 2190 | USD 2690 | GBP 1890
Publication Time19
Editorial Review ProcessOpen peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2001
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 19
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessOpen peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC0
OA statementVisit website
View less

Planning to publish in BMC Cardiovascular Disorders ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in BMC Cardiovascular Disorders

Conservative management of iatrogenic pulmonary vein obstruction following transcatheter sinus venosus ASD repair: a case insight and literature review.
  • 1 Jul 2026
  • BMC cardiovascular disorders
Arterial stiffness in patients with moderate to severe psoriasis on long term treatment with infliximab.
  • 1 Jul 2026
  • BMC cardiovascular disorders
'Aspirin versus ticagrelor for the management after coronary revascularization - a systematic review and meta‑analysis of randomised trials'.
  • 1 Jul 2026
  • BMC cardiovascular disorders
Age, rather than hypertension duration, drives coronary endothelial degradation: an in situ post-mortem analysis.
  • 1 Jul 2026
  • BMC cardiovascular disorders
In-hospital SGLT2 inhibitor initiation, prescribing gaps, and 30-day all-cause readmission in heart failure with reduced ejection fraction: a US post-guideline cohort study.
  • 30 Jun 2026
  • BMC cardiovascular disorders
Age- and sex-specific normative values for reticulocyte indices and their relation to early-stage CKM syndrome.
  • 30 Jun 2026
  • BMC cardiovascular disorders
Conservative management of iatrogenic pulmonary vein obstruction following transcatheter sinus venosus ASD repair: a case insight and literature review.
  • 1 Jul 2026
  • BMC cardiovascular disorders
Arterial stiffness in patients with moderate to severe psoriasis on long term treatment with infliximab.
  • 1 Jul 2026
  • BMC cardiovascular disorders
'Aspirin versus ticagrelor for the management after coronary revascularization - a systematic review and meta‑analysis of randomised trials'.
  • 1 Jul 2026
  • BMC cardiovascular disorders
Age, rather than hypertension duration, drives coronary endothelial degradation: an in situ post-mortem analysis.
  • 1 Jul 2026
  • BMC cardiovascular disorders
In-hospital SGLT2 inhibitor initiation, prescribing gaps, and 30-day all-cause readmission in heart failure with reduced ejection fraction: a US post-guideline cohort study.
  • 30 Jun 2026
  • BMC cardiovascular disorders
Age- and sex-specific normative values for reticulocyte indices and their relation to early-stage CKM syndrome.
  • 30 Jun 2026
  • BMC cardiovascular disorders

FAQs on BMC Cardiovascular Disorders